Journal article
Treatment of Proximal Vein Thrombosis With Subcutaneous Low-Molecular-Weight Heparin vs Intravenous Heparin: An Economic Perspective
Abstract
Background: Subcutaneous low-molecular-weight heparin is at least as effective and safe as classic intravenous heparin therapy for the treatment of proximal vein thrombosis. Anticoagulant monitoring is not required with low-molecular-weight heparin.Objective: To perform an economic evaluation of these therapeutic approaches by comparing cost and effectiveness.Patients and Methods: A randomized trial in 432 patients with proximal vein thrombosis …
Authors
Hull RD; Raskob GE; Rosenbloom D; Pineo GF; Lerner RG; Gafni A; Trowbridge AA; Elliott CG; Green D; Feinglass J
Journal
JAMA Internal Medicine, Vol. 157, No. 3, pp. 289–294
Publisher
American Medical Association (AMA)
Publication Date
February 10, 1997
DOI
10.1001/archinte.1997.00440240051008
ISSN
2168-6106